First Time Loading...
U

Ucrest Bhd
KLSE:UCREST

Watchlist Manager
Ucrest Bhd
KLSE:UCREST
Watchlist
Price: 0.105 MYR 5% Market Closed
Updated: Apr 28, 2024

Intrinsic Value

Ucrest Bhd.is an investment holding company, which engages in the design, development, and marketing of information technology products and services. [ Read More ]

The intrinsic value of one UCREST stock under the Base Case scenario is 0.059 MYR. Compared to the current market price of 0.105 MYR, Ucrest Bhd is Overvalued by 44%.

Key Points:
UCREST Intrinsic Value
Base Case
0.059 MYR
Overvaluation 44%
Intrinsic Value
Price
U
Base Case Scenario

Valuation Backtest
Ucrest Bhd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling UCREST stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Ucrest Bhd

Provide an overview of the primary business activities
of Ucrest Bhd.

What unique competitive advantages
does Ucrest Bhd hold over its rivals?

What risks and challenges
does Ucrest Bhd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ucrest Bhd.

Provide P/S
for Ucrest Bhd.

Provide P/E
for Ucrest Bhd.

Provide P/OCF
for Ucrest Bhd.

Provide P/FCFE
for Ucrest Bhd.

Provide P/B
for Ucrest Bhd.

Provide EV/S
for Ucrest Bhd.

Provide EV/GP
for Ucrest Bhd.

Provide EV/EBITDA
for Ucrest Bhd.

Provide EV/EBIT
for Ucrest Bhd.

Provide EV/OCF
for Ucrest Bhd.

Provide EV/FCFF
for Ucrest Bhd.

Provide EV/IC
for Ucrest Bhd.

Compare the intrinsic valuations
of Ucrest Bhd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ucrest Bhd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ucrest Bhd compared to its peers.

Compare the P/E ratios
of Ucrest Bhd against its peers.

Discuss the investment returns and shareholder value creation
comparing Ucrest Bhd with its peers.

Analyze the financial leverage
of Ucrest Bhd compared to its main competitors.

Show all profitability ratios
for Ucrest Bhd.

Provide ROE
for Ucrest Bhd.

Provide ROA
for Ucrest Bhd.

Provide ROIC
for Ucrest Bhd.

Provide ROCE
for Ucrest Bhd.

Provide Gross Margin
for Ucrest Bhd.

Provide Operating Margin
for Ucrest Bhd.

Provide Net Margin
for Ucrest Bhd.

Provide FCF Margin
for Ucrest Bhd.

Show all solvency ratios
for Ucrest Bhd.

Provide D/E Ratio
for Ucrest Bhd.

Provide D/A Ratio
for Ucrest Bhd.

Provide Interest Coverage Ratio
for Ucrest Bhd.

Provide Altman Z-Score Ratio
for Ucrest Bhd.

Provide Quick Ratio
for Ucrest Bhd.

Provide Current Ratio
for Ucrest Bhd.

Provide Cash Ratio
for Ucrest Bhd.

What is the historical Revenue growth
over the last 5 years for Ucrest Bhd?

What is the historical Net Income growth
over the last 5 years for Ucrest Bhd?

What is the current Free Cash Flow
of Ucrest Bhd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ucrest Bhd.

Financials

Balance Sheet Decomposition
Ucrest Bhd

Current Assets 37.1m
Cash & Short-Term Investments 22.4m
Receivables 14.6m
Non-Current Assets 15.6m
PP&E 273k
Intangibles 3.7m
Other Non-Current Assets 11.7m
Current Liabilities 13.2m
Accounts Payable 11.5m
Other Current Liabilities 1.7m
Efficiency

Earnings Waterfall
Ucrest Bhd

Revenue
17.3m MYR
Cost of Revenue
-10.8m MYR
Gross Profit
6.5m MYR
Operating Expenses
-81k MYR
Operating Income
6.4m MYR
Other Expenses
-44k MYR
Net Income
6.4m MYR

Free Cash Flow Analysis
Ucrest Bhd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

UCREST Profitability Score
Profitability Due Diligence

Ucrest Bhd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROE is Increasing
39/100
Profitability
Score

Ucrest Bhd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

UCREST Solvency Score
Solvency Due Diligence

Ucrest Bhd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
90/100
Solvency
Score

Ucrest Bhd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

UCREST Price Targets Summary
Ucrest Bhd

There are no price targets for UCREST.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

UCREST Price
Ucrest Bhd

1M 1M
-100%
6M 6M
-38%
1Y 1Y
-13%
3Y 3Y
-76%
5Y 5Y
-58%
10Y 10Y
+110%
Annual Price Range
0.105
52w Low
0.095
52w High
64.85
Price Metrics
Average Annual Return -15.75%
Standard Deviation of Annual Returns 20.61%
Max Drawdown -100%
Shares Statistics
Market Capitalization 77.9m MYR
Shares Outstanding 741 877 000
Percentage of Shares Shorted
N/A

UCREST Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Ucrest Bhd

Country

Malaysia

Industry

Health Care

Market Cap

77.9m MYR

Dividend Yield

0%

Description

Ucrest Bhd.is an investment holding company, which engages in the design, development, and marketing of information technology products and services. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2001-01-01. The firm is a provider of advanced cloud hospital and mobile health services. The firm provides iMedic application, which helps people with chronic conditions and other health conditions who may need to track daily health metrics, such as blood pressure, glucose, and oxygen saturation and more. The iMedic Cloud Hospital is used by renowned doctors and patients in the United States, China, Singapore, Malaysia, Taiwan, Indonesia, Russia and Middle East countries for the diagnosis, management and treatment of chronic diseases, such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation and other diseases. Patients can upload test reports and Computed tomography (CT) scan, X-radiation (X-ray) and ultrasound done at the hospital to i-Medic Cloud Hospital.

Contact

SELANGOR
Petaling Jaya
Lot 6.04, Level 6, KPMG Tower, 8, First Avenue, Bandar Utama
+60377289880
https://www.ucrest.net

IPO

2001-01-01

Employees

-

Officers

Founder, Chairman & MD
Mr. Kah Yee Eg
Senior Vice President of Operations
Miss Geok Lui Ng
Company Secretary
Ee Lin Kooi

See Also

Discover More
What is the Intrinsic Value of one UCREST stock?

The intrinsic value of one UCREST stock under the Base Case scenario is 0.059 MYR.

Is UCREST stock undervalued or overvalued?

Compared to the current market price of 0.105 MYR, Ucrest Bhd is Overvalued by 44%.